Clinical and microbiological effectiveness of limosilactobacillus reuteri in supportive periodontal therapy: randomized clinical trial.
- 2025-08-26
- RCT
- Clinical oral investigations 29(9)
- Magda Mensi
- Eleonora Scotti
- Silvia Marchetti
- Annamaria Sordillo
- Gianluca Garzetti
- Stefano Calza
- Mark J Buijs
- Egija Zaura
- Bernd W Brandt
- PubMed: 40856866
- DOI: 10.1007/s00784-025-06508-w
- High evidence
- Clinical
The test group showed a lower percentage of BOP at sites with plaque at T2 and T3.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 3 weeks of bi-daily supplementation with lozenges containing probiotic (specific CFU not stated in abstract)